|
1
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lau NC, Lim LP, Weinstein EG and Bartel
DP: An abundant class of tiny RNAs with probable regulatory roles
in Caenorhabditis elegans. Science. 294:858–862. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee RC and Ambros V: An extensive class of
small RNAs in Caenorhabditis elegans. Science. 294:862–864. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cable J, Heard E, Hirose T, Prasanth KV,
Chen LL, Henninger JE, Quinodoz SA, Spector DL, Diermeier SD,
Porman AM, et al: Noncoding RNAs: Biology and applications-a
keystone symposia report. Ann N Y Acad Sci. 1506:118–141. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bejerano G, Pheasant M, Makunin I, Stephen
S, Kent WJ, Mattick JS and Haussler D: Ultraconserved elements in
the human genome. Science. 304:1321–1325. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hill M and Tran N: miRNA interplay:
Mechanisms and consequences in cancer. Dis Model Mech.
14:dmm0476622021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rivera-Barahona A, Pérez B, Richard E and
Desviat LR: Role of miRNAs in human disease and inborn errors of
metabolism. J Inherit Metab Dis. 40:471–480. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jeffries J, Zhou W, Hsu AY and Deng Q:
miRNA-223 at the crossroads of inflammation and cancer. Cancer
Lett. 451:136–141. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang L, Liao Y and Tang L: MicroRNA-34
family: A potential tumor suppressor and therapeutic candidate in
cancer. J Exp Clin Cancer Res. 38:532019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rani V and Sengar RS: Biogenesis and
mechanisms of microRNA-mediated gene regulation. Biotechnol Bioeng.
119:685–692. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Su Y, Yuan J, Zhang F, Lei Q, Zhang T, Li
K, Guo J, Hong Y, Bu G, Lv X, et al: MicroRNA-181a-5p and
microRNA-181a-3p cooperatively restrict vascular inflammation and
atherosclerosis. Cell Death Dis. 10:3652019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao H, Guo Y, Sun Y, Zhang N and Wang X:
miR-181a/b-5p ameliorates inflammatory response in
monocrotaline-induced pulmonary arterial hypertension by targeting
endocan. J Cell Physiol. 235:4422–4433. 2020. View Article : Google Scholar
|
|
17
|
Lozano-Bartolomé J, Llauradó G,
Portero-Otin M, Altuna-Coy A, Rojo-Martínez G, Vendrell J, Jorba R,
Rodríguez-Gallego E and Chacón MR: Altered expression of
miR-181a-5p and miR-23a-3p Is associated with obesity and
TNFα-induced insulin resistance. J Clin Endocrinol Metab.
103:1447–1458. 2018. View Article : Google Scholar
|
|
18
|
Korhan P, Erdal E and Atabey N:
MiR-181a-5p is downregulated in hepatocellular carcinoma and
suppresses motility, invasion and branching-morphogenesis by
directly targeting c-Met. Biochem Biophys Res Commun.
450:1304–1312. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang M, Zhang W, Zhang R, Liu P, Ye Y, Yu
W, Guo X and Yu J: Cancer exosome-derived miR-9 and miR-181a
promote the development of early-stage MDSCs via interfering with
SOCS3 and PIAS3 respectively in breast cancer. Oncogene.
39:4681–4694. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang Z, Wan X, Gu Z, Zhang H, Yang X, He
L, Miao R, Zhong Y and Zhao H: Evolution of the mir-181 microRNA
family. Comput Biol Med. 52:82–87. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smillie CL, Sirey T and Ponting CP:
Complexities of post-transcriptional regulation and the modeling of
ceRNA crosstalk. Crit Rev Biochem Mol Biol. 53:231–245. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen H, Wang L, Xiong J, Ren C, Gao C,
Ding W, Zhu D, Ma D and Wang H: Long non-coding RNA CCAT1 promotes
cervical cancer cell proliferation and invasion by regulating the
miR-181a-5p/MMP14 axis. Cell Cycle. 18:1110–1121. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shang A, Wang W, Gu C, Chen W, Lu W, Sun Z
and Li D: Long non-coding RNA CCAT1 promotes colorectal cancer
progression by regulating miR-181a-5p expression. Aging (Albany
NY). 12:8301–8320. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li S, Yang J, Xia Y, Fan Q and Yang KP:
Long noncoding RNA NEAT1 promotes proliferation and invasion via
targeting miR-181a-5p in non-small cell lung cancer. Oncol Res.
26:289–296. 2018. View Article : Google Scholar
|
|
26
|
Hai Ping P, Feng Bo T, Li L, Nan Hui Y and
Hong Z: IL-1β/NF-kb signaling promotes colorectal cancer cell
growth through miR-181a/PTEN axis. Arch Biochem Biophys. 604:20–26.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang X, Li X, Tan F, Yu N and Pei H:
STAT1 inhibits MiR-181a expression to suppress colorectal cancer
cell proliferation through PTEN/Akt. J Cell Biochem. 118:3435–3443.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi L, Li X, Wu Z, Li X, Nie J, Guo M, Mei
Q and Han W: DNA methylation-mediated repression of
miR-181a/135a/302c expression promotes the microsatellite-unstable
colorectal cancer development and 5-FU resistance via targeting
PLAG1. J Genet Genomics. 45:205–214. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Cen A, Yang Y, Ye H, Li J, Liu S
and Zhao L: miR-181a, delivered by hypoxic PTC-secreted exosomes,
inhibits DACT2 by downregulating MLL3, leading to YAP-VEGF-mediated
angiogenesis. Mol Ther Nucleic Acids. 24:610–621. 2021. View Article : Google Scholar :
|
|
30
|
Sun X, Wei L, Chen Q and Terek RM:
MicroRNA regulates vascular endothelial growth factor expression in
chondrosarcoma cells. Clin Orthop Relat Res. 473:907–913. 2015.
View Article : Google Scholar :
|
|
31
|
Hanahan D: Hallmarks of cancer: New
dimensions. Cancer Discov. 12:31–46. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Svoronos AA, Engelman DM and Slack FJ:
OncomiR or tumor suppressor? The duplicity of MicroRNAs in cancer.
Cancer Res. 76:3666–3670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar
|
|
34
|
Han P, Li JW, Zhang BM, Lv JC, Li YM, Gu
XY, Yu ZW, Jia YH, Bai XF, Li L, et al: The lncRNA CRNDE promotes
colorectal cancer cell proliferation and chemoresistance via
miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol
Cancer. 16:92017. View Article : Google Scholar
|
|
35
|
Lv SY, Shan TD, Pan XT, Tian ZB, Liu XS,
Liu FG, Sun XG, Xue HG, Li XH, Han Y, et al: The lncRNA ZEB1-AS1
sponges miR-181a-5p to promote colorectal cancer cell proliferation
by regulating Wnt/β-catenin signaling. Cell Cycle. 17:1245–1254.
2018. View Article : Google Scholar :
|
|
36
|
Sun C, Shen C, Zhang Y and Hu C: LncRNA
ANRIL negatively regulated chitooligosaccharide-induced
radiosensitivity in colon cancer cells by sponging miR-181a-5p. Adv
Clin Exp Med. 30:55–65. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chang L, Yuan Y, Li C, Guo T, Qi H, Xiao
Y, Dong X, Liu Z and Liu Q: Upregulation of SNHG6 regulates ZEB1
expression by competitively binding miR-101-3p and interacting with
UPF1 in hepatocellular carcinoma. Cancer Lett. 383:183–194. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu C, Sun J, Leng X and Yang J: Long
noncoding RNA SNHG6 functions as a competing endogenous RNA by
sponging miR-181a-5p to regulate E2F5 expression in colorectal
cancer. Cancer Manag Res. 11:611–624. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chi J, Liu S, Wu Z, Shi Y, Shi C, Zhang T,
Xiong B, Zeng Y and Dong X: circNSUN2 promotes the malignant
biological behavior of colorectal cancer cells via the
miR-181a-5p/ROCK2 axis. Oncol Rep. 46:1422021. View Article : Google Scholar :
|
|
40
|
Zhao S, Mi Y, Zheng B, Wei P, Gu Y, Zhang
Z, Xu Y, Cai S, Li X and Li D: Highly-metastatic colorectal cancer
cell released miR-181a-5p-rich extracellular vesicles promote liver
metastasis by activating hepatic stellate cells and remodelling the
tumour microenvironment. J Extracell Vesicles. 11:e121862022.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ji D, Chen Z, Li M, Zhan T, Yao Y, Zhang
Z, Xi J, Yan L and Gu J: MicroRNA-181a promotes tumor growth and
liver metastasis in colorectal cancer by targeting the tumor
suppressor WIF-1. Mol Cancer. 13:862014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Z, Wang H, Xu Z, Sun Y and Han J:
Expression and mechanism of microRNA-181A on incidence and survival
in late liver metastases of colorectal cancer. Oncol Rep.
35:1403–1408. 2016. View Article : Google Scholar
|
|
43
|
Wei Z, Cui L, Mei Z, Liu M and Zhang D:
miR-181a mediates metabolic shift in colon cancer cells via the
PTEN/AKT pathway. FEBS Lett. 588:1773–1779. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sun W, Wang X, Li J, You C, Lu P, Feng H,
Kong Y, Zhang H, Liu Y, Jiao R, et al: MicroRNA-181a promotes
angiogenesis in colorectal cancer by targeting SRCIN1 to promote
the SRC/VEGF signaling pathway. Cell Death Dis. 9:4382018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang Q, Wang C, Li R, Liu J, Wang J, Wang
T and Wang B: The BAP31/miR-181a-5p/RECK axis promotes angiogenesis
in colorectal cancer via fibroblast activation. Front Oncol.
13:10569032023. View Article : Google Scholar :
|
|
46
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen G, Shen ZL, Wang L, Lv CY, Huang XE
and Zhou RP: Hsa-miR-181a-5p expression and effects on cell
proliferation in gastric cancer. Asian Pac J Cancer Prev.
14:3871–3875. 2013. View Article : Google Scholar
|
|
48
|
Ge S, Zhang H, Deng T, Sun W, Ning T, Fan
Q, Wang Y, Wang X, Zhang Q, Zhou Z, et al: MiR-181a, a new
regulator of TGF-β signaling, can promote cell migration and
proliferation in gastric cancer. Invest New Drugs. 37:923–934.
2019. View Article : Google Scholar
|
|
49
|
Yu J, Qi J, Sun X, Wang W, Wei G, Wu Y,
Gao Q and Zheng J: MicroRNA-181a promotes cell proliferation and
inhibits apoptosis in gastric cancer by targeting RASSF1A. Oncol
Rep. 40:1959–1970. 2018.
|
|
50
|
Ding L, Tian Y, Wang L, Bi M, Teng D and
Hong S: Hypermethylated long noncoding RNA MEG3 promotes the
progression of gastric cancer. Aging (Albany NY). 11:8139–8155.
2019. View Article : Google Scholar
|
|
51
|
Liu Z, Sun F, Hong Y, Liu Y, Fen M, Yin K,
Ge X, Wang F, Chen X and Guan W: MEG2 is regulated by miR-181a-5p
and functions as a tumour suppressor gene to suppress the
proliferation and migration of gastric cancer cells. Mol Cancer.
16:1332017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mi Y, Zhang D, Jiang W, Weng J, Zhou C,
Huang K, Tang H, Yu Y, Liu X, Cui W, et al: miR-181a-5p promotes
the progression of gastric cancer via RASSF6-mediated MAPK
signalling activation. Cancer Lett. 389:11–22. 2017. View Article : Google Scholar
|
|
53
|
Lu Q, Chen Y, Sun D, Wang S, Ding K, Liu
M, Zhang Y, Miao Y, Liu H and Zhou F: MicroRNA-181a functions as an
oncogene in gastric cancer by targeting caprin-1. Front Pharmacol.
9:15652019. View Article : Google Scholar :
|
|
54
|
Zhao J, Nie Y, Wang H and Lin Y: MiR-181a
suppresses autophagy and sensitizes gastric cancer cells to
cisplatin. Gene. 576:828–833. 2016. View Article : Google Scholar
|
|
55
|
Lin F, Li Y, Yan S, Liu S, Qian W, Shen D,
Lin Q and Mao W: MicroRNA-181a inhibits tumor proliferation,
invasiveness, and metastasis and is downregulated in gastric
cancer. Oncol Res. 22:75–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lu Z, Luo T, Pang T, Du Z, Yin X, Cui H,
Fang G and Xue X: MALAT1 promotes gastric adenocarcinoma through
the MALAT1/miR-181a-5p/AKT3 axis. Open Biol. 9:1900952019.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhuang X, Chen Y, Wu Z, Xu Q, Chen M, Shao
M, Cao X, Zhou Y, Xie M, Shi Y, et al: Mitochondrial miR-181a-5p
promotes glucose metabolism reprogramming in liver cancer by
regulating the electron transport chain. Carcinogenesis.
41:972–983. 2020. View Article : Google Scholar
|
|
58
|
Bi JG, Zheng JF, Li Q, Bao SY, Yu XF, Xu P
and Liao CX: MicroRNA-181a-5p suppresses cell proliferation by
targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in
hepatocellular carcinoma. Int J Biochem Cell Biol. 106:107–116.
2019. View Article : Google Scholar
|
|
59
|
Guo J, Ma Y, Peng X, Jin H and Liu J:
LncRNA CCAT1 promotes autophagy via regulating ATG7 by sponging
miR-181 in hepatocellular carcinoma. J Cell Biochem.
120:17975–17983. 2019. View Article : Google Scholar
|
|
60
|
Chang S, Chen B, Wang X, Wu K and Sun Y:
Long non-coding RNA XIST regulates PTEN expression by sponging
miR-181a and promotes hepatocellular carcinoma progression. BMC
Cancer. 17:2482017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Yang S, Wang P, Wang S, Cong A, Zhang Q,
Shen W, Li X, Zhang W and Han G: miRNA-181a-5p enhances the
sensitivity of cells to cisplatin in esophageal adenocarcinoma by
targeting CBLB. Cancer Manag Res. 12:4981–4990. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Ilic M and Ilic I: Epidemiology of
pancreatic cancer. World J Gastroenterol. 22:9694–9705. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Liu J, Xu D, Wang Q, Zheng D, Jiang X and
Xu L: LPS induced miR-181a promotes pancreatic cancer cell
migration via targeting PTEN and MAP2K4. Dig Dis Sci. 59:1452–1460.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wang L, Bi R, Li L, Zhou K and Yin H:
lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer
cells to gemcitabine by targeting inhibition of miR-181a and
targeting HMGB1-induced autophagy. Aging (Albany NY).
13:19272–19281. 2021. View Article : Google Scholar
|
|
65
|
Harðardottir H, Jonsson S, Gunnarsson O,
Hilmarsdottir B, Asmundsson J, Gudmundsdottir I, Saevarsdottir VY,
Hansdottir S, Hannesson P and Gudbjartsson T: Advances in lung
cancer diagnosis and treatment-a review. Laeknabladid. 108:17–29.
2022.In Icelandic.
|
|
66
|
Duma N, Santana-Davila R and Molina JR:
Non-small cell lung cancer: Epidemiology, screening, diagnosis, and
treatment. Mayo Clin Proc. 94:1623–1640. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Ma Z, Qiu X, Wang D, Li Y, Zhang B, Yuan
T, Wei J, Zhao B, Zhao X, Lou J, et al: MiR-181a-5p inhibits cell
proliferation and migration by targeting Kras in non-small cell
lung cancer A549 cells. Acta Biochim Biophys Sin (Shanghai).
47:630–638. 2015. View Article : Google Scholar
|
|
68
|
Shi Q, Zhou Z, Ye N, Chen Q, Zheng X and
Fang M: MiR-181a inhibits non-small cell lung cancer cell
proliferation by targeting CDK1. Cancer Biomark. 20:539–546. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wang L, Zhang L and Wang L: SNHG7
contributes to the progression of non-small-cell lung cancer via
the SNHG7/miR-181a-5p/E2F7 axis. Cancer Manag Res. 12:3211–3222.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Cao Y, Zhao D, Li P, Wang L, Qiao B, Qin
X, Li L and Wang Y: MicroRNA-181a-5p impedes IL-17-induced nonsmall
cell lung cancer proliferation and migration through targeting
VCAM-1. Cell Physiol Biochem. 42:346–356. 2017. View Article : Google Scholar
|
|
71
|
Li L, Ye D, Liu L, Li X, Liu J, Su S, Lu W
and Yu Z: Long noncoding RNA SNHG7 accelerates proliferation,
migration and invasion of non-small cell lung cancer cells by
suppressing miR-181a-5p through AKT/mTOR signaling pathway. Cancer
Manag Res. 12:8303–8312. 2020. View Article : Google Scholar :
|
|
72
|
Zhang LX, Gao J, Long X, Zhang PF, Yang X,
Zhu SQ, Pei X, Qiu BQ, Chen SW, Lu F, et al: The circular RNA
circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung
adenocarcinomas and squamous cell carcinomas via the
miR-181a-5p/CARM1 axis. Mol Cancer. 21:1102022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Fu S, Fu Y, Chen F, Hu Y, Quan B and Zhang
J: Overexpression of MYCT1 inhibits proliferation and induces
apoptosis in human acute myeloid leukemia HL-60 and KG-1a cells in
vitro and in vivo. Front Pharmacol. 9:10452018. View Article : Google Scholar :
|
|
74
|
Wang HT, Tong X, Zhang ZX, Sun YY, Yan W,
Xu ZM and Fu WN: MYCT1 represses apoptosis of laryngeal cancerous
cells through the MAX/miR-181a/NPM1 pathway. FEBS J. 286:3892–3908.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Hao YR, Zhang DJ, Fu ZM, Guo YY and Guan
GF: Long non-coding RNA ANRIL promotes proliferation,
clonogenicity, invasion and migration of laryngeal squamous cell
carcinoma by regulating miR-181a/Snai2 axis. Regen Ther.
11:282–289. 2019. View Article : Google Scholar :
|
|
76
|
Wilkinson L and Gathani T: Understanding
breast cancer as a global health concern. Br J Radiol.
95:202110332022. View Article : Google Scholar :
|
|
77
|
Strotbek M, Schmid S, Sánchez-González I,
Boerries M, Busch H and Olayioye MA: miR-181 elevates Akt signaling
by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast
cancer. Int J Cancer. 140:2310–2320. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Taylor MA, Sossey-Alaoui K, Thompson CL,
Danielpour D and Schiemann WP: TGF-β upregulates miR-181a
expression to promote breast cancer metastasis. J Clin Invest.
123:150–163. 2013. View Article : Google Scholar
|
|
79
|
Liu K, Xie F, Gao A, Zhang R, Zhang L,
Xiao Z, Hu Q, Huang W, Huang Q, Lin B, et al: SOX2 regulates
multiple malignant processes of breast cancer development through
the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis. Mol Cancer. 16:622017.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhai Z, Mu T, Zhao L, Li Y, Zhu D and Pan
Y: MiR-181a-5p facilitates proliferation, invasion, and glycolysis
of breast cancer through NDRG2-mediated activation of PTEN/AKT
pathway. Bioengineered. 13:83–95. 2022. View Article : Google Scholar :
|
|
81
|
Alexandrova E, Lamberti J, Saggese P,
Pecoraro G, Memoli D, Cappa VM, Ravo M, Iorio R, Tarallo R, Rizzo
F, et al: Small non-coding RNA profiling identifies miR-181a-5p as
a mediator of estrogen receptor beta-induced inhibition of
cholesterol biosynthesis in triple-negative breast cancer. Cells.
9:8742020. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Gu M, Wang L, Yang C, Li X, Jia C, Croteau
S, Ruan X and Hardy P: Micro-RNA-181a suppresses progestin-promoted
breast cancer cell growth. Maturitas. 114:60–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Cai G, Wang Y, Houda T, Yang C, Wang L, Gu
M, Mueck A, Croteau S, Ruan X and Hardy P: MicroRNA-181a suppresses
norethisterone-promoted tumorigenesis of breast epithelial MCF10A
cells through the PGRMC1/EGFR-PI3K/Akt/mTOR signaling pathway.
Transl Oncol. 14:1010682021. View Article : Google Scholar
|
|
84
|
Liu Y, Cheng T, Du Y, Hu X and Xia W:
LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion
of breast cancer via targeting KLF6 and KLF15. BMC Mol Cell Biol.
21:692020. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Tsu V and Jerónimo J: Saving the world's
women from cervical cancer. N Engl J Med. 374:2509–2511. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Yang M, Zhai X, Ge T, Yang C and Lou G:
miR-181a-5p promotes proliferation and invasion and inhibits
apoptosis of cervical cancer cells via regulating inositol
polyphosphate-5-phosphatase A (INPP5A). Oncol Res. 26:703–712.
2018. View Article : Google Scholar
|
|
87
|
Xu H, Zhu J, Hu C, Song H and Li Y:
Inhibition of microRNA-181a may suppress proliferation and invasion
and promote apoptosis of cervical cancer cells through the
PTEN/Akt/FOXO1 pathway. J Physiol Biochem. 72:721–732. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Ke G, Liang L, Yang JM, Huang X, Han D,
Huang S, Zhao Y, Zha R, He X and Wu X: MiR-181a confers resistance
of cervical cancer to radiation therapy through targeting the
pro-apoptotic PRKCD gene. Oncogene. 32:3019–3027. 2013. View Article : Google Scholar
|
|
89
|
Luo C and Qiu J: miR-181a inhibits
cervical cancer development via downregulating GRP78. Oncol Res.
25:1341–1348. 2017. View Article : Google Scholar
|
|
90
|
Zhu L, Zhang Q, Li S, Jiang S, Cui J and
Dang G: Interference of the long noncoding RNA CDKN2B-AS1
upregulates miR-181a-5p/TGFβI axis to restrain the metastasis and
promote apoptosis and senescence of cervical cancer cells. Cancer
Med. 8:1721–1730. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zhang L, Liu SK, Song L and Yao HR:
SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation,
migration and invasion of cervical cancer by sponging miR-181a.
Artif Cells Nanomed Biotechnol. 47:555–564. 2019. View Article : Google Scholar
|
|
92
|
Hu Z, Zhu D, Wang W, Li W, Jia W, Zeng X,
Ding W, Yu L, Wang X, Wang L, et al: Genome-wide profiling of HPV
integration in cervical cancer identifies clustered genomic hot
spots and a potential microhomology-mediated integration mechanism.
Nat Genet. 47:158–163. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Felix AS, Scott McMeekin D, Mutch D,
Walker JL, Creasman WT, Cohn DE, Ali S, Moore RG, Downs LS, Ioffe
OB, et al: Associations between etiologic factors and mortality
after endometrial cancer diagnosis: The NRG oncology/gynecologic
oncology group 210 trial. Gynecol Oncol. 139:70–76. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Geletina NS, Kobelev VS, Babayants EV,
Feng L, Pustylnyak VO and Gulyaeva LF: PTEN negative correlates
with miR-181a in tumour tissues of non-obese endometrial cancer
patients. Gene. 655:20–24. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Yu J, Jiang L, Gao Y, Sun Q, Liu B, Hu Y
and Han X: LncRNA CCAT1 negatively regulates miR-181a-5p to promote
endometrial carcinoma cell proliferation and migration. Exp Ther
Med. 17:4259–4266. 2019.PubMed/NCBI
|
|
96
|
Dong P, Xiong Y, Konno Y, Ihira K,
Kobayashi N, Yue J and Watari H: Long non-coding RNA DLEU2 drives
EMT and glycolysis in endometrial cancer through HK2 by
competitively binding with miR-455 and by modulating the
EZH2/miR-181a pathway. J Exp Clin Cancer Res. 40:2162021.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Parikh A, Lee C, Joseph P, Marchini S,
Baccarini A, Kolev V, Romualdi C, Fruscio R, Shah H, Wang F, et al:
microRNA-181a has a critical role in ovarian cancer progression
through the regulation of the epithelial-mesenchymal transition.
Nat Commun. 5:29772014. View Article : Google Scholar
|
|
98
|
Belur Nagaraj A, Knarr M, Sekhar S, Connor
RS, Joseph P, Kovalenko O, Fleming A, Surti A, Nurmemmedov E,
Beltrame L, et al: The miR-181a-SFRP4 axis regulates Wnt activation
to drive stemness and platinum resistance in ovarian cancer. Cancer
Res. 81:2044–2055. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Zhou CK, Check DP, Lortet-Tieulent J,
Laversanne M, Jemal A, Ferlay J, Bray F, Cook MB and Devesa SS:
Prostate cancer incidence in 43 populations worldwide: An analysis
of time trends overall and by age group. Int J Cancer.
138:1388–1400. 2016. View Article : Google Scholar :
|
|
100
|
Ding X, Xu X, He XF, Yuan Y, Chen C, Shen
XY, Su S, Chen Z, Xu ST and Huang YH: Muscleblind-like 1 antisense
RNA 1 inhibits cell proliferation, invasion, and migration of
prostate cancer by sponging miR-181a-5p and regulating
PTEN/PI3K/AKT/mTOR signaling. Bioengineered. 12:803–814. 2021.
View Article : Google Scholar
|
|
101
|
Liang J, Li X, Li Y, Wei J, Daniels G,
Zhong X, Wang J, Sfanos K, Melamed J, Zhao J and Lee P: LEF1
targeting EMT in prostate cancer invasion is mediated by miR-181a.
Am J Cancer Res. 5:1124–1132. 2015.
|
|
102
|
Hu W, Yan F, Ru Y, Xia M, Yan G, Zhang M,
Wang H, Wu G, Yao L, Shen L, et al: MIIP inhibits EMT and cell
invasion in prostate cancer through miR-181a/b-5p-KLF17 axis. Am J
Cancer Res. 10:630–647. 2020.PubMed/NCBI
|
|
103
|
Mao W, Huang X, Wang L, Zhang Z, Liu M, Li
Y, Luo M, Yao X, Fan J and Geng J: Circular RNA hsa_circ_0068871
regulates FGFR3 expression and activates STAT3 by targeting
miR-181a-5p to promote bladder cancer progression. J Exp Clin
Cancer Res. 38:1692019. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Lai Y, Zhao L, Hu J, Quan J, Chen P, Xu J,
Guan X, Lai Y and Ni L: microRNA-181a-5p functions as an oncogene
in renal cell carcinoma. Mol Med Rep. 17:8510–8517. 2018.PubMed/NCBI
|
|
105
|
Lei Z, Ma X, Li H, Zhang Y, Gao Y, Fan Y,
Li X, Chen L, Xie Y, Chen J, et al: Up-regulation of miR-181a in
clear cell renal cell carcinoma is associated with lower KLF6
expression, enhanced cell proliferation, accelerated cell cycle
transition, and diminished apoptosis. Urol Oncol. 36:93.e23–93.e37.
2018. View Article : Google Scholar
|
|
106
|
Coca-Pelaz A, Shah JP, Hernandez-Prera JC,
Ghossein RA, Rodrigo JP, Hartl DM, Olsen KD, Shaha AR, Zafereo M,
Suarez C, et al: Papillary thyroid cancer-aggressive variants and
impact on management: A narrative review. Adv Ther. 37:3112–3128.
2020. View Article : Google Scholar :
|
|
107
|
Wang Y, Ye H, Yang Y, Li J, Cen A and Zhao
L: microRNA-181a promotes the oncogene S100A2 and enhances
papillary thyroid carcinoma growth by mediating the expression of
histone demethylase KDM5C. J Endocrinol Invest. 45:17–28. 2022.
View Article : Google Scholar
|
|
108
|
Sun CX, Liu BJ, Su Y, Shi GW, Wang Y and
Chi JF: MiR-181a promotes cell proliferation and migration through
targeting KLF15 in papillary thyroid cancer. Clin Transl Oncol.
24:66–75. 2022. View Article : Google Scholar
|
|
109
|
Le F, Li HM, Lv QL, Chen JJ, Lin QX, Ji YL
and Yi B: lncRNA ZNF674-AS1 inhibits the migration, invasion and
epithelial-mesenchymal transition of thyroid cancer cells by
modulating the miR-181a/SOCS4 axis. Mol Cell Endocrinol.
544:1115512022. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Gierlikowski W, Broniarek K, Cheda Ł,
Rogulski Z and Kotlarek-Łysakowska M: MiR-181a-5p regulates NIS
expression in papillary thyroid carcinoma. Int J Mol Sci.
22:60672021. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Ju R, Huang Y, Guo Z, Han L, Ji S, Zhao L
and Long J: The circular RNAs differential expression profiles in
the metastasis of salivary adenoid cystic carcinoma cells. Mol Cell
Biochem. 476:1269–1282. 2021. View Article : Google Scholar
|
|
112
|
Nabhan M, Louka ML, Khairy E, Tash F,
Ali-Labib R and El-Habashy S: MicroRNA-181a and its target Smad 7
as potential biomarkers for tracking child acute lymphoblastic
leukemia. Gene. 628:253–258. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Liu X, Liao W, Peng H, Luo X, Luo Z, Jiang
H and Xu L: miR-181a promotes G1/S transition and cell
proliferation in pediatric acute myeloid leukemia by targeting ATM.
J Cancer Res Clin Oncol. 142:77–87. 2016. View Article : Google Scholar
|
|
114
|
Lyu X, Li J, Yun X, Huang R, Deng X, Wang
Y, Chen Y and Xiao G: miR-181a-5p, an inducer of Wnt-signaling,
facilitates cell proliferation in acute lymphoblastic leukemia.
Oncol Rep. 37:1469–1476. 2017. View Article : Google Scholar
|
|
115
|
Assmann JLJC, Leon LG, Stavast CJ, van den
Bogaerdt SE, Schilperoord-Vermeulen J, Sandberg Y, Bellido M,
Erkeland SJ, Feith DJ, Loughran TP Jr and Langerak AW: miR-181a is
a novel player in the STAT3-mediated survival network of TCRαβ+
CD8+ T large granular lymphocyte leukemia. Leukemia. 36:983–993.
2022. View Article : Google Scholar
|
|
116
|
Fei J, Li Y, Zhu X and Luo X: miR-181a
post-transcriptionally downregulates oncogenic RalA and contributes
to growth inhibition and apoptosis in chronic myelogenous leukemia
(CML). PLoS One. 7:e328342012. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Sun Y, Jiang T, Jia Y, Zou J, Wang X and
Gu W: LncRNA MALAT1/miR-181a-5p affects the proliferation and
adhesion of myeloma cells via regulation of Hippo-YAP signaling
pathway. Cell Cycle. 18:2509–2523. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Chen L, Hu N, Wang C, Zhao H and Gu Y:
Long non-coding RNA CCAT1 promotes multiple myeloma progression by
acting as a molecular sponge of miR-181a-5p to modulate HOXA1
expression. Cell Cycle. 17:319–329. 2018. View Article : Google Scholar :
|
|
119
|
Martelli M, Ferreri AJ, Agostinelli C, Di
Rocco A, Pfreundschuh M and Pileri SA: Diffuse large B-cell
lymphoma. Crit Rev Oncol Hematol. 87:146–171. 2013. View Article : Google Scholar
|
|
120
|
Kozloski GA, Jiang X, Bhatt S, Ruiz J,
Vega F, Shaknovich R, Melnick A and Lossos IS: miR-181a negatively
regulates NF-κB signaling and affects activated B-cell-like diffuse
large B-cell lymphoma pathogenesis. Blood. 127:2856–2866. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Bao Z, Wang Y, Wang Q, Fang S, Shan X,
Wang J and Jiang T: Intratumor heterogeneity, microenvironment, and
mechanisms of drug resistance in glioma recurrence and evolution.
Front Med. 15:551–561. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Lei B, Huang Y, Zhou Z, Zhao Y, Thapa AJ,
Li W, Cai W and Deng Y: Circular RNA hsa_circ_0076248 promotes
oncogenesis of glioma by sponging miR-181a to modulate SIRT1
expression. J Cell Biochem. 120:6698–6708. 2019. View Article : Google Scholar
|
|
123
|
Hanif F, Muzaffar K, Perveen K, Malhi SM
and Simjee SU: Glioblastoma multiforme: A review of its
epidemiology and pathogenesis through clinical presentation and
treatment. Asian Pac J Cancer Prev. 18:3–9. 2017.PubMed/NCBI
|
|
124
|
Rezaei T, Hejazi M, Mansoori B, Mohammadi
A, Amini M, Mosafer J, Rezaei S, Mokhtarzadeh A and Baradaran B:
microRNA-181a mediates the chemo-sensitivity of glioblastoma to
carmustine and regulates cell proliferation, migration, and
apoptosis. Eur J Pharmacol. 888:1734832020. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Huang SX, Zhao ZY, Weng GH, He XY, Wu CJ,
Fu CY, Sui ZY, Ma YS and Liu T: Upregulation of miR-181a suppresses
the formation of glioblastoma stem cells by targeting the Notch2
oncogene and correlates with good prognosis in patients with
glioblastoma multiforme. Biochem Biophys Res Commun. 486:1129–1136.
2017. View Article : Google Scholar
|
|
126
|
Marisetty A, Wei J, Kong LY, Ott M, Fang
D, Sabbagh A and Heimberger AB: MiR-181 family modulates
osteopontin in glioblastoma multiforme. Cancers (Basel).
12:38132020. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Ma J, Yao Y, Wang P, Liu Y, Zhao L, Li Z,
Li Z and Xue Y: MiR-181a regulates blood-tumor barrier permeability
by targeting Krüppel-like factor 6. J Cereb Blood Flow Metab.
34:1826–1836. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Liao Y, Shen L, Zhao H, Liu Q, Fu J, Guo
Y, Peng R and Cheng L: LncRNA CASC2 interacts with miR-181a to
modulate glioma growth and resistance to TMZ through PTEN pathway.
J Cell Biochem. 118:1889–1899. 2017. View Article : Google Scholar
|
|
129
|
Matthay KK, Maris JM, Schleiermacher G,
Nakagawara A, Mackall CL, Diller L and Weiss WA: Neuroblastoma. Nat
Rev Dis Primers. 2:160782016. View Article : Google Scholar
|
|
130
|
Liu X, Peng H, Liao W, Luo A, Cai M, He J,
Zhang X, Luo Z, Jiang H and Xu L: MiR-181a/b induce the growth,
invasion, and metastasis of neuroblastoma cells through targeting
ABI1. Mol Carcinog. 57:1237–1250. 2018. View Article : Google Scholar
|
|
131
|
Orr BA: Pathology, diagnostics, and
classification of medulloblastoma. Brain Pathol. 30:664–678. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Zhu LY, Wu XY, Liu XD, Zheng DF, Li HS,
Yang B, Zhang J and Chang Q: Aggressive medulloblastoma-derived
exosomal miRNAs promote in vitro invasion and migration of tumor
cells via Ras/MAPK pathway. J Neuropathol Exp Neurol. 79:734–745.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Wang Z, Wang X, Zhou H, Dan X, Jiang L and
Wu Y: Long non-coding RNA CASC2 inhibits tumorigenesis via the
miR-181a/PLXNC1 axis in melanoma. Acta Biochim Biophys Sin
(Shanghai). 50:263–272. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Zhang S, Wan H and Zhang X: LncRNA
LHFPL3-AS1 contributes to tumorigenesis of melanoma stem cells via
the miR-181a-5p/BCL2 pathway. Cell Death Dis. 11:9502020.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Waldman A and Schmults C: Cutaneous
squamous cell carcinoma. Hematol Oncol Clin North Am. 33:1–12.
2019. View Article : Google Scholar
|
|
136
|
Chitsazzadeh V, Nguyen TN, de Mingo Pulido
A, Bittencourt BB, Du L, Adelmann CH, Ortiz Rivera I, Nguyen KA,
Guerra LD, Davis A, et al: miR-181a promotes multiple
protumorigenic functions by targeting TGFβR3. J Invest Dermatol.
142:1956–1965.e2. 2022. View Article : Google Scholar
|
|
137
|
Neu J, Dziunycz PJ, Dzung A, Lefort K,
Falke M, Denzler R, Freiberger SN, Iotzova-Weiss G, Kuzmanov A,
Levesque MP, et al: miR-181a decelerates proliferation in cutaneous
squamous cell carcinoma by targeting the proto-oncogene KRAS. PLoS
One. 12:e01850282017. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Ba Z, Gu L, Hao S, Wang X, Cheng Z and Nie
G: Downregulation of lncRNA CASC2 facilitates osteosarcoma growth
and invasion through miR-181a. Cell Prolif. 51:e124092018.
View Article : Google Scholar
|
|
140
|
Zhao A, Liu W, Cui X, Wang N, Wang Y, Sun
L, Xue H, Wu L, Cui S, Yang Y and Bai R: lncRNA TUSC7 inhibits
osteosarcoma progression through the miR-181a/RASSF6 axis. Int J
Mol Med. 47:583–594. 2021. View Article : Google Scholar :
|
|
141
|
Mutlu S, Mutlu H, Kirkbes S, Eroglu S,
Kabukcuoglu YS, Kabukcuoglu F, Duymus TM, ISık M and Ulasli M: The
expression of miR-181a-5p and miR-371b-5p in chondrosarcoma. Eur
Rev Med Pharmacol Sci. 19:2384–2388. 2015.PubMed/NCBI
|
|
142
|
Sun X, Charbonneau C, Wei L, Chen Q and
Terek RM: miR-181a targets RGS16 to promote chondrosarcoma growth,
angiogenesis, and metastasis. Mol Cancer Res. 13:1347–1357. 2015.
View Article : Google Scholar :
|
|
143
|
Ho PTB, Clark IM and Le LTT:
MicroRNA-based diagnosis and therapy. Int J Mol Sci. 23:71672022.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Guo LJ and Zhang QY: Decreased serum
miR-181a is a potential new tool for breast cancer screening. Int J
Mol Med. 30:680–686. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Zhang H, Zhu M, Shan X, Zhou X, Wang T,
Zhang J, Tao J, Cheng W, Chen G, Li J, et al: A panel of
seven-miRNA signature in plasma as potential biomarker for
colorectal cancer diagnosis. Gene. 687:246–254. 2019. View Article : Google Scholar
|
|
146
|
Lin Z, Chen Y, Lin Y, Lin H, Li H, Su X,
Fang Z, Wang J, Wei Q, Teng J and Zhang Z: Potential miRNA
biomarkers for the diagnosis and prognosis of esophageal cancer
detected by a novel absolute quantitative RT-qPCR method. Sci Rep.
10:200652020. View Article : Google Scholar :
|
|
147
|
He S, Zeng S, Zhou ZW, He ZX and Zhou SF:
Hsa-microRNA-181a is a regulator of a number of cancer genes and a
biomarker for endometrial carcinoma in patients: A bioinformatic
and clinical study and the therapeutic implication. Drug Des Devel
Ther. 9:1103–1175. 2015.PubMed/NCBI
|
|
148
|
Shan X, Zhang H, Zhang L, Zhou X, Wang T,
Zhang J, Shu Y, Zhu W, Wen W and Liu P: Identification of four
plasma microRNAs as potential biomarkers in the diagnosis of male
lung squamous cell carcinoma patients in China. Cancer Med.
7:2370–2381. 2018. View Article : Google Scholar :
|
|
149
|
Nishimura J, Handa R, Yamamoto H, Tanaka
F, Shibata K, Mimori K, Takemasa I, Mizushima T, Ikeda M, Sekimoto
M, et al: microRNA-181a is associated with poor prognosis of
colorectal cancer. Oncol Rep. 28:2221–2226. 2012. View Article : Google Scholar
|
|
150
|
Panoutsopoulou K, Avgeris M, Magkou P,
Mavridis K, Dreyer T, Dorn J, Obermayr E, Reinthaller A,
Michaelidou K, Mahner S, et al: miR-181a overexpression predicts
the poor treatment response and early-progression of serous ovarian
cancer patients. Int J Cancer. 147:3560–3573. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Papadimitriou MA, Papanota AM, Adamopoulos
PG, Pilala KM, Liacos CI, Malandrakis P, Mavrianou-Koutsoukou N,
Patseas D, Eleutherakis-Papaiakovou E, Gavriatopoulou M, et al
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a
overexpression predicts short-term disease progression and poor
post-treatment outcome. Br J Cancer. 126:79–90. 2022. View Article : Google Scholar
|
|
152
|
Meijer LL, Garajová I, Caparello C, Le
Large TYS, Frampton AE, Vasile E, Funel N, Kazemier G and
Giovannetti E: Plasma miR-181a-5p downregulation predicts response
and improved survival after FOLFIRINOX in pancreatic ductal
adenocarcinoma. Ann Surg. 271:1137–1147. 2020. View Article : Google Scholar
|
|
153
|
Egyed B, Kutszegi N, Sági JC, Gézsi A,
Rzepiel A, Visnovitz T, Lőrincz P, Müller J, Zombori M, Szalai C,
et al: MicroRNA-181a as novel liquid biopsy marker of central
nervous system involvement in pediatric acute lymphoblastic
leukemia. J Transl Med. 18:2502020. View Article : Google Scholar :
|
|
154
|
Xue WX, Zhang MY, Rui Li, Liu X, Yin YH
and Qu YQ: Serum miR-1228-3p and miR-181a-5p as noninvasive
biomarkers for non-small cell lung cancer diagnosis and prognosis.
Biomed Res Int. 2020:96018762020. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Gao W, Yu Y, Cao H, Shen H, Li X, Pan S
and Shu Y: Deregulated expression of miR-21, miR-143 and miR-181a
in non small cell lung cancer is related to clinicopathologic
characteristics or patient prognosis. Biomed Pharmacother.
64:399–408. 2010. View Article : Google Scholar
|
|
156
|
Schwind S, Maharry K, Radmacher MD, Mrózek
K, Holland KB, Margeson D, Whitman SP, Hickey C, Becker H, Metzeler
KH, et al: Prognostic significance of expression of a single
microRNA, miR-181a, in cytogenetically normal acute myeloid
leukemia: A cancer and leukemia group B study. J Clin Oncol.
28:5257–5264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Wang Y, Fang YX, Dong B, Du X, Wang J,
Wang X, Gao WQ and Xue W: Discovery of extracellular vesicles
derived miR-181a-5p in patient's serum as an indicator for
bone-metastatic prostate cancer. Theranostics. 11:878–892. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Bjørnetrø T, Redalen KR, Meltzer S,
Thusyanthan NS, Samiappan R, Jegerschöld C, Handeland KR and Ree
AH: An experimental strategy unveiling exosomal microRNAs 486-5p,
181a-5p and 30d-5p from hypoxic tumour cells as circulating
indicators of high-risk rectal cancer. J Extracell Vesicles.
8:15672192019. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Leonetti A, Capula M, Minari R, Mazzaschi
G, Gregori A, El Hassouni B, Papini F, Bordi P, Verzè M, Avan A, et
al: Dynamic evaluation of circulating miRNA profile in EGFR-mutated
NSCLC patients treated with EGFR-TKIs. Cells. 10:15202021.
View Article : Google Scholar :
|
|
160
|
Pichler M, Winter E, Ress AL, Bauernhofer
T, Gerger A, Kiesslich T, Lax S, Samonigg H and Hoefler G: miR-181a
is associated with poor clinical outcome in patients with
colorectal cancer treated with EGFR inhibitor. J Clin Pathol.
67:198–203. 2014. View Article : Google Scholar
|
|
161
|
Robak P, Dróżdż I, Jarych D, Mikulski D,
Węgłowska E, Siemieniuk-Ryś M, Misiewicz M, Stawiski K, Fendler W,
Szemraj J, et al: The value of serum MicroRNA expression signature
in predicting refractoriness to bortezomib-based therapy in
multiple myeloma patients. Cancers (Basel). 12:25692020. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Nishida N, Arizumi T, Hagiwara S, Ida H,
Sakurai T and Kudo M: MicroRNAs for the prediction of early
response to sorafenib treatment in human hepatocellular carcinoma.
Liver Cancer. 6:113–125. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Seipel K, Messerli C, Wiedemann G, Bacher
U and Pabst T: MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers
in acute myeloid leukemia patients treated with intensive induction
chemotherapy and autologous stem cell transplantation. Leuk Res.
89:1062962020. View Article : Google Scholar
|
|
164
|
Danza K, Silvestris N, Simone G, Signorile
M, Saragoni L, Brunetti O, Monti M, Mazzotta A, De Summa S, Mangia
A and Tommasi S: Role of miR-27a, miR-181a and miR-20b in gastric
cancer hypoxia-induced chemoresistance. Cancer Biol Ther.
17:400–406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Petrillo M, Zannoni GF, Beltrame L,
Martinelli E, DiFeo A, Paracchini L, Craparotta I, Mannarino L,
Vizzielli G, Scambia G, et al: Identification of high-grade serous
ovarian cancer miRNA species associated with survival and drug
response in patients receiving neoadjuvant chemotherapy: A
retrospective longitudinal analysis using matched tumor biopsies.
Ann Oncol. 27:625–634. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Shi L, Zhu W, Huang Y, Zhuo L, Wang S,
Chen S, Zhang B and Ke B: Cancer-associated fibroblast-derived
exosomal microRNA-20a suppresses the PTEN/PI3K-AKT pathway to
promote the progression and chemoresistance of non-small cell lung
cancer. Clin Transl Med. 12:e9892022. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Novoa Díaz MB, Martín MJ and Gentili C:
Tumor microenvironment involvement in colorectal cancer progression
via Wnt/β-catenin pathway: Providing understanding of the complex
mechanisms of chemoresistance. World J Gastroenterol. 28:3027–3046.
2022. View Article : Google Scholar
|
|
168
|
Kousar K, Ahmad T, Abduh MS, Kanwal B,
Shah SS, Naseer F and Anjum S: miRNAs in regulation of tumor
microenvironment, chemotherapy resistance, immunotherapy modulation
and miRNA therapeutics in cancer. Int J Mol Sci. 23:138222022.
View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Shah MY, Ferrajoli A, Sood AK,
Lopez-Berestein G and Calin GA: microRNA therapeutics in cancer-an
emerging concept. EBioMedicine. 12:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Zhang C, Xu C, Gao X and Yao Q:
Platinum-based drugs for cancer therapy and anti-tumor strategies.
Theranostics. 12:2115–2132. 2022. View Article : Google Scholar
|
|
171
|
Zhao X, Wang J, Zhu R, Zhang J and Zhang
Y: DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin
resistance of lung squamous cell carcinoma through modulating
miR-181a-5p/miR-382-5p/CELF1 axis. Sci Rep. 11:210142021.
View Article : Google Scholar :
|
|
172
|
Sun J: VDR/vitamin D receptor regulates
autophagic activity through ATG16L1. Autophagy. 12:1057–1058. 2016.
View Article : Google Scholar
|
|
173
|
Lin J, Chen X, Sun M, Qu X, Wang Y, Li C,
Li X, Zhao L, Su Z and Ye H: Upregulation of microRNA-181a-5p
increases the sensitivity of HS578T breast cancer cells to
cisplatin by inducing vitamin D receptor-mediated cell autophagy.
Oncol Lett. 21:2472021. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Galluzzi L, Morselli E, Vitale I, Kepp O,
Senovilla L, Criollo A, Servant N, Paccard C, Hupé P, Robert T, et
al: miR-181a and miR-630 regulate cisplatin-induced cancer cell
death. Cancer Res. 70:1793–1803. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Hu X, Lou T, Yuan C, Wang Y, Tu X, Wang Y
and Zhang T: Effects of lncRNA ANRIL-knockdown on the
proliferation, apoptosis and cell cycle of gastric cancer cells.
Oncol Lett. 22:6212021. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Wu J, Ma C, Tang X, Shi Y, Liu Z, Chai X,
Tang Q, Li L and Hann SS: The regulation and interaction of PVT1
and miR181a-5p contributes to the repression of SP1 expression by
the combination of XJD decoction and cisplatin in human lung cancer
cells. Biomed Pharmacother. 121:1096322020. View Article : Google Scholar
|
|
177
|
Bai H, Cao Z, Deng C, Zhou L and Wang C:
miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C
by inducing apoptosis. J Cancer Res Clin Oncol. 138:595–602. 2012.
View Article : Google Scholar
|
|
178
|
Ping W, Gao Y, Fan X, Li W, Deng Y and Fu
X: MiR-181a contributes gefitinib resistance in non-small cell lung
cancer cells by targeting GAS7. Biochem Biophys Res Commun.
495:2482–2489. 2018. View Article : Google Scholar
|
|
179
|
Barbato A, Iuliano A, Volpe M, D'Alterio
R, Brillante S, Massa F, De Cegli R, Carrella S, Salati M, Russo A,
et al: Integrated genomics identifies miR-181/TFAM pathway as a
critical driver of drug resistance in melanoma. Int J Mol Sci.
22:18012021. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Tabatabaei SN, Derbali RM, Yang C,
Superstein R, Hamel P, Chain JL and Hardy P: Co-delivery of
miR-181a and melphalan by lipid nanoparticles for treatment of
seeded retinoblastoma. J Control Release. 298:177–185. 2019.
View Article : Google Scholar : PubMed/NCBI
|
